Hexaware Technologies posted revenue and margins below our estimates, which was attributed to slip in a few big accounts during the quarter. While its revenue growth is expected to recover going forward, based on continuity in strong wins and potency in BFS & Healthcare & Insurance verticals, we moderate the extent of our optimism. JFM quarter was marked by NorthAm-led growth, homogeneous decline across service-lines and US$36mn TCV wins (US$120mn in CY15). Though we moderate our earnings estimate, we continue to maintain our BUY...